The University of Chicago Header Logo

Connection

Sarah Ackroyd to Quality-Adjusted Life Years

Back to Details
This is a "connection" page, showing publications Sarah Ackroyd has written about Quality-Adjusted Life Years.
Sarah Ackroyd
Connection Strength
0.182
Quality-Adjusted Life Years
  1. Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis. Gynecol Oncol. 2021 08; 162(2):249-255.
    View in: PubMed
    Score: 0.182
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.